News

EPAM Emerges as Top IT Vendor in Europe for Third Year Running

EPAM Emerges as Top IT Vendor in Europe for Third Year Running

EPAM Triumphs as a Top IT Vendor in Europe

EPAM Systems, Inc. (NYSE: EPAM) has once again cemented its reputation as a leader in the field of digital and AI transformation. The company has been recognized as an 'Exceptional Performer' for the third consecutive year in Whitelane Research's recent study, showcasing outstanding client satisfaction ratings across several crucial categories. This accolade highlights EPAM's commitment to delivering exceptional service and profound technological excellence.

Significant Achievement in Application Services

EPAM has been awarded the top position among IT vendors in Europe, receiving high ratings in multiple categories that underscore its exceptional capabilities. According to the recent Whitelane Research study, EPAM not only ranked #1 in Application Services but also secured the highest ranking for General Satisfaction among clients.

Insights from Company Leadership

Enver Amdiy, Senior Vice President and Head of Business in Europe at EPAM, expressed gratitude towards clients for their continued trust, emphasizing how this recognition reflects the company's dedication to client success. Amdiy stated, "These results are a testament to EPAM's focus on delivering real value and results across our clients' initiatives, enhancing the overall digital transformation experience."

The Whitelane Research Study Context

The study involved feedback from more than 2,500 participants from top IT spending organizations across Europe, evaluating nearly 7,000 unique IT sourcing relationships. EPAM's exceptional performance was particularly notable in key performance indicators, reflecting a deep commitment to service quality and client satisfaction. Key categories where EPAM excelled include:

  • Application Services: Ranked #1 with a remarkable rating of 83%
  • General Satisfaction: Ranked #1 with a significant rating of 82%
  • Service Delivery Quality: Ranked #1 with a top rating of 85%
  • Account Management Quality: Achieved a rating of 84%
  • Innovation: Ranked #1 with a rating of 76%
  • Transformation: Also ranked #1 with a top rating of 75%

The Future of IT with EPAM

The recognition from Whitelane Research underscores EPAM's role as a preferred partner for organizations looking to invest in AI and GenAI over the coming years. Alex van den Bergh, Head of Research at Whitelane, highlighted the importance of collaborating with an IT partner like EPAM, especially as businesses navigate challenges related to data quality and systems integration.

Expanding IT Capabilities Across Europe

EPAM's leadership position as an IT provider is further demonstrated through its consistent ranking as a Top IT Vendor in various European markets throughout 2025. The company has successfully achieved recognition in Germany, Switzerland, the UK, Ireland, and the Nordics, reinforcing its reputation as a trusted partner across different countries. This continual acknowledgment showcases EPAM's capacity to maintain high standards across diverse geographical regions.

About EPAM Systems

Since its inception in 1993, EPAM Systems has leveraged deep software engineering expertise to offer cutting-edge digital engineering, cloud solutions, and AI-enabled transformation services. EPAM focuses on addressing clients' challenges by combining integrated strategy with over 30 years of engineering execution, ensuring swift market entry and maximizing value from digital investments.

Through its innovative solutions like EPAM AI/RUN™ and initiatives such as DIALX Lab, EPAM integrates advanced AI technologies to enhance clients' competitive edge while driving significant industry impact. The company prides itself on delivering tailored strategies that improve not only business metrics but also enhance people's lives and operational efficiency across diverse sectors.

Frequently Asked Questions

What recognition has EPAM received in 2025?

EPAM was recognized as a top IT vendor in Europe, earning 'Exceptional Performer' status based on client satisfaction ratings.

What are the key performance categories where EPAM excelled?

EPAM ranked #1 in Application Services, General Satisfaction, Service Delivery Quality, Account Management Quality, Innovation, and Transformation.

Who is the Senior Vice President at EPAM?

Enver Amdiy serves as the Senior Vice President and Head of Business in Europe for EPAM.

How many participants were involved in the Whitelane Research study?

Over 2,500 participants from leading IT spending organizations across Europe contributed feedback for the Whitelane Research study.

What has EPAM focused on since its founding?

EPAM has focused on offering digital engineering, cloud solutions, and AI transformation services to global enterprises and startups since 1993.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 60

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 14

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 28

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 36

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 168

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 74

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 57

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading

Top 5 Most Recently Viewed Articles

2026 Best Buddies Challenge Hits $4M For Inclusion

Updated Category News Views 7

A Record-Breaking Year for Best Buddies Everyone loves a good underdog story, and every now and then, you get one that really hits home. The 27th Annual Best Buddies Challenge in Hyannis Port did exactly that, raking in a whopping $4 million and drawing a crowd of nearly 1,000 participants. The event serves as both a fundraiser and a community builder, spotlighting its...

Continue Reading
MSP Recovery Implements Reverse Stock Split for Compliance

Updated Category News Views 239

MSP Recovery Announces a Reverse Stock Split MSP Recovery, Inc. (NASDAQ: MSPR), a leader in Medicare, Medicaid, and secondary payer reimbursement recovery, recently announced a reverse stock split of its Class A common stock at a ratio of 1-for-7. This strategic move aims to ensure compliance with Nasdaq's minimum bid price requirement. Details of the Stock Split The...

Continue Reading
The Value of a $1000 Investment in Primerica Over 10 Years

Updated Category News Views 127

Understanding Primerica's Growth Over the Last Decade Primerica Inc (NYSE: PRI) has shown remarkable performance, outperforming the market by an annualized rate of 8.02%. This impressive rate results in an average annual return of 19.51% for the investors over the past ten years. As of now, the company has a market valuation of approximately $8.63 billion, indicating...

Continue Reading
Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth

Updated Category News Views 161

Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced an exciting initiative aimed at enhancing cell and gene therapy manufacturing. Eight G-Rex Grants, amounting to nearly $2 million, have been awarded to distinguished recipients within the...

Continue Reading